Staff Profile
Sylvia Zhang
Research Assistant
- Email: xinyue.zhang@ncl.ac.uk
- Personal Website: https://io.nihr.ac.uk/
- Address: NIHR Innovation Observatory
Newcastle University
Room 3.12, The Catalyst
3 Science Square
Newcastle Helix
Newcastle Upon Tyne
NE4 5TG
I'm a Research Assistant (Horizon Scanning and Evidence Synthesis) at NIHR Innovation Observatory, also a member of NICE External Assessment Groups (EAG) in Newcastle. My role here involves horizon scanning and synthesising evidence for a variety of purposes and stakeholders including NICE, and providing statistical support for research projects.
Before joining NIHR IO, I was an NIHR Predoctoral Fellow in Medical Statistics at Biostatistics Research Group within the Population Health Sciences Institute at Newcastle University.
About the NIHR Innovation Observatory
Home - NIHR Innovation Observatory
The NIHR Innovation Observatory is a world leading health and care innovation scanning centre providing data-driven insights to foster innovation and equitable access to high quality care. We aim to transform health systems and improve population health by providing advanced data-driven insights that foster innovation and equitable access to high quality care. At the core of our work is the development of data-driven methods to identify, capture and synthesise intelligence on new health innovations. We develop and share cutting edge methods in horizon scanning, building capacity in the systems across the public, voluntary and industry sectors.
We deliver essential intelligence and insights about medicines and MedTech innovation to the National Institute of Health and Care Excellence (NICE), NHS England, the Medicines and Healthcare Products Regulatory Agency (MHRA), the NIHR, the UK Health Security Agency, the Department for Health and Social Care and industry - allowing these organisations to prepare for policies, regulation and frontline delivery for new, emerging and disruptive technologies.
-
Articles
- Wyatt NJ, Watson H, Anderson CA, Kennedy NA, Raine T, Ahmad T, Allerton D, Bardgett M, Clark E, Clewes D, Martin CC, Doona M, Doyle JA, Frith K, Hancock H, Hart A, Hildreth V, Irving PM, Iqbal S, Kennedy C, King A, Lawrence S, Lees CW, Lees R, Letchford L, Liddle T, Lindsay JO, Maier RH, Mansfield JC, Marchesi JR, McGregor N, McIntyre RE, Ostermayer J, Osunnuyi T, Powell N, Prescott NJ, Satsangi J, Sharma S, Shrestha T, Speight A, Strickland M, Wason JMS, Whelan K, Wood R, Young GR, Zhang X, Parkes M, Stewart CJ, Jostins-Dean L, Lamb CA. Defining predictors of responsiveness to advanced therapies in Crohn’s disease and ulcerative colitis: Protocol for the IBD-RESPONSE and nested CD-metaRESPONSE prospective, multicentre, observational cohort study in precision medicine. BMJ Open 2024, 14(4).
- Lv D, Grayling M, Zhang X, Zhao Q, Zheng H. A Bayesian approach to pilot-pivotal trials for bioequivalence assessment. BMC Medical Research Methodology 2023, 23, 301.